Skip to content

EOPA Elongated One-Piece Arterial Cannula With Guidewire

by Medtronic Cardiac Surgical Products

510(k) K000274

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK000274 Date10 Feb 2000ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DWF
Device Class
Class II
Regulation
21 CFR Part 870.4210
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The EOPA Elongated One-Piece Arterial Cannula With Guidewire is a vascular cannula designed for use in cardiopulmonary bypass procedures. It facilitates arterial access by providing a lumen for blood flow during extracorporeal circulation, ensuring efficient perfusion support during cardiac surgery.

This device is supplied as a single-use, sterile product and is intended for use in controlled clinical environments such as operating rooms. It is available in specific French sizes (e.g., 20 Fr, 22 Fr) and may include a guidewire for insertion. The cannula is classified as a Class II medical device under FDA regulations (K000274) and is authorized via a Special 510(k) clearance under the Cardiovascular advisory committee.

Other devices from Medtronic Cardiac Surgical Products

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary use of the EOPA Elongated One-Piece Arterial Cannula With Guidewire in a clinical setting?

    The EOPA Elongated One-Piece Arterial Cannula With Guidewire is specifically designed for use during cardiopulmonary bypass procedures. It provides arterial access to facilitate blood flow through the cannula during extracorporeal circulation, ensuring effective perfusion support for patients undergoing cardiac surgery.

  • Is this cannula intended for single-use or can it be reused?

    The EOPA Elongated One-Piece Arterial Cannula With Guidewire is explicitly supplied as a single-use device. This ensures sterility and safety for controlled clinical environments like operating rooms, where it is intended to be used only once per patient.

  • What French sizes are available for the EOPA Elongated One-Piece Arterial Cannula With Guidewire?

    The cannula is available in specific French sizes, including 20 Fr and 22 Fr, though the exact range of sizes may vary based on the model or batch. These sizes are designed to accommodate different patient anatomies during cardiopulmonary bypass procedures.

  • How is the sterility of this device maintained, and what storage conditions should be followed?

    The EOPA Elongated One-Piece Arterial Cannula With Guidewire is sterile as supplied, ensuring it is ready for immediate use in sterile clinical environments like operating rooms. While the device data does not specify exact storage conditions, sterile medical devices like this typically require protection from contamination—such as keeping packaging intact, avoiding exposure to moisture or extreme temperatures, and storing in a clean, dry area until use.

  • What regulatory pathway was followed for the clearance of this device, and which advisory committee was involved?

    The EOPA Elongated One-Piece Arterial Cannula With Guidewire received a Special 510(k) clearance under the FDA’s Cardiovascular (CV) advisory committee. This clearance was granted in 2000, confirming its substantial equivalence to a predicate device, and it is classified as a Class II medical device under FDA regulations.